CHICAGOMillions of heart patients whose disease has been treated with tiny devices called stents may need to stay on an aggressive course of bloodthinning drugs longer than current practice to get the most protection against future heart attacks a major study presented Sunday suggests In the study which involved nearly  patients those treated with aspirin plus a second anticlotting drug for  months had a sharp reduction in the risk of heart attacks and other complications compared with those who stopped one of
  